Examination of factors impacting spitting or vomiting among children under 5 years of age during seasonal malaria chemoprevention: a quantitative study in Burkina Faso, Chad, Nigeria and Togo
Abstract Background Since 2012, the World Health Organization has recommended seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) for children aged 3–59 months in regions where malaria transmission is seasonal. Full ingestion of SMC medicines without spitti...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-11-01
|
Series: | Tropical Medicine and Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41182-024-00642-z |